查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945357

2026年全球植入式神經刺激設備市場報告

Implantable Neurostimulation Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入式神經刺激設備市場發展迅速，預計將從2025年的56.2億美元成長到2026年的62.7億美元，複合年成長率達11.7%。過去幾年的成長可歸因於神經系統疾病盛行率的上升、疼痛管理治療的擴展、植入式刺激技術的應用、神經調控療法在臨床上的日益普及以及植入式電子系統的廣泛使用。

預計未來幾年植入式神經刺激設備市場將快速成長，到2030年市場規模將達到100.2億美元，複合年成長率（CAGR）為12.4%。預測期內的成長要素包括：對非藥物療法的需求不斷成長、對精準神經調控的日益重視、門診神經治療的擴展、腦機介面研究投入的增加以及刺激演算法的不斷創新。預測期內的主要趨勢包括：先進神經刺激療法的普及率不斷提高、可充電刺激器的廣泛應用、個性化神經調控療法的日益普及、多適應症神經刺激系統的擴展以及對長期治療效果的日益關注。

預計未來幾年，神經系統疾病盛行率的不斷上升將推動植入式神經刺激設備市場的成長。神經系統疾病是指影響神經系統結構和功能的疾病，會導致癱瘓、癲癇發作和認知障礙等症狀。高血壓、發育異常、創傷和損傷等風險因素的增加是導致這些疾病盛行率上升的原因之一。當傳統治療方法無效或效果不佳時，植入式神經刺激設備可用於調節神經活動並緩解症狀。例如，根據美國非營利組織阿茲海默症協會統計，截至2024年，約有690萬65歲及以上的美國人患有阿茲海默症，其中73%的患者年齡在75歲及以上。預計到2050年，這數字將達到1,270萬。因此，神經系統疾病盛行率的不斷上升預計將推動對植入式神經刺激設備的需求。

植入式神經刺激設備市場的公司正致力於開發先進系統，例如可充電式腦電感測神經刺激設備，旨在為運動障礙和神經系統疾病患者提供更個人化和適應性的治療方案。這些設備植入體內後，可在提供標靶刺激的同時記錄即時腦波訊號，使臨床醫生能夠根據個別神經活動和長期治療需求來微調治療方案。例如，2024年1月，美國醫療設備製造商Medtronic）的Percept RC神經刺激設備獲得了美國食品藥物管理局（FDA）的核准。 Percept RC是一款可充電式深部腦部刺激（DBS）系統，採用美敦力專有的BrainSense技術。該設備能夠捕獲並追蹤腦波訊號，從而最佳化個人化治療。憑藉至少15年的使用壽命、靈活的定向刺激編程和快速充電功能，該設備為運動障礙患者提供了持久耐用且可自訂的治療選擇。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球植入式神經刺激設備市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 先進神經刺激療法的應用日益廣泛
    • 可充電式刺激器的使用率不斷提高
    • 擴大個人化神經調控療法的應用
    • 擴展多適應症神經刺激系統
    • 人們越來越關注長期治療效果

第5章 終端用戶產業市場分析

  • 醫院
  • 神經科診所
  • 疼痛管理中心
  • 門診手術中心
  • 復健中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球植入式神經刺激設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球植入式神經刺激設備市場規模、對比及成長率分析
  • 全球植入式神經刺激設備市場表現：規模與成長，2020-2025年
  • 全球植入式神經刺激設備市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 脊髓刺激（SCS）、胃電刺激（GES）、深部腦部刺激（DBS）、薦椎神經刺激（SNS）、迷走神經刺激（VNS）、其他類型
  • 透過使用
  • 疼痛管理、帕金森氏症、尿失禁和糞便失禁、癲癇、胃輕癱及其他適應症
  • 最終用戶
  • 醫院、診所及門診手術中心
  • 按類型細分：脊髓刺激（SCS）
  • 可充電式SCS設備，不可充電式SCS設備
  • 按類型細分：胃電刺激（GES）
  • 植入式胃刺激器，可調式胃刺激器
  • 按類型細分：深部腦部刺激（DBS）
  • 用於治療運動障礙的深部腦部刺激（DBS）裝置，用於治療精神疾病的深部腦部刺激（DBS）裝置
  • 按類型細分：薦椎神經刺激（SNS）
  • 用於治療尿失禁的薦神經刺激裝置，用於治療糞便失禁的薦神經刺激裝置
  • 按類型細分：迷走神經刺激（VNS）
  • 用於治療癲癇的迷走神經刺激裝置，用於治療憂鬱症的迷走神經刺激裝置
  • 按類型細分：其他類型
  • 周邊神經刺激（PNS）、皮質刺激裝置、新型神經刺激技術

第10章 區域與國家分析

  • 全球植入式神經刺激設備市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球植入式神經刺激設備市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 植入式神經刺激設備市場：競爭格局與市場佔有率（2024 年）
  • 植入式神經刺激設備市場：公司估值矩陣
  • 植入式神經刺激設備市場：公司概況
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • St. Jude Medical LLC
    • LivaNova PLC

第37章：其他領先和創新企業

  • Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Curonix LLC, Inspire Medical Systems Inc., SetPoint Medical Corporation, ElectroCore Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年植入式神經刺激設備市場：提供新機會的國家
  • 2030年植入式神經刺激設備市場：充滿新機會的細分市場
  • 2030年植入式神經刺激設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4TINDE02_G26Q1

Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body to modulate nerve activity, offering a sophisticated approach for managing conditions that may not respond adequately to medication alone, thereby enhancing patients' quality of life.

The primary types of implantable neurostimulation devices include spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and others. Spinal cord stimulation (SCS) therapy uses mild electrical currents to block pain signals from reaching the brain, providing effective management for chronic pain conditions. These devices are applied in treating pain management, Parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis, and other conditions. They are used by various end-users, including hospitals, clinics, and ambulatory surgical centers.

Tariffs are impacting the implantable neurostimulation devices market by increasing costs of imported microelectronics, electrodes, batteries, sensors, and software-enabled control units. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported advanced components, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing therapy system prices and slowing adoption in cost-sensitive healthcare systems. However, they are also driving local manufacturing, regional R&D investment, and development of cost-efficient neurostimulation platforms.

The implantable neurostimulation devices market research report is one of a series of new reports from The Business Research Company that provides implantable neurostimulation devices market statistics, including implantable neurostimulation devices industry global market size, regional shares, competitors with a implantable neurostimulation devices market share, detailed implantable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable neurostimulation devices industry. This implantable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable neurostimulation devices market size has grown rapidly in recent years. It will grow from $5.62 billion in 2025 to $6.27 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising prevalence of neurological disorders, expansion of pain management treatments, adoption of implantable stimulation technologies, increasing clinical acceptance of neuromodulation, availability of implantable electronic systems.

The implantable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $10.02 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing demand for non-pharmacological therapies, rising focus on precision neuromodulation, expansion of outpatient neurological treatments, growing investment in brain-machine interface research, increasing innovation in stimulation algorithms. Major trends in the forecast period include increasing deployment of advanced neurostimulation therapies, rising adoption of rechargeable stimulation devices, growing use of personalized neuromodulation treatments, expansion of multi-indication neurostimulation systems, enhanced focus on long-term therapy effectiveness.

The increasing prevalence of neurological disorders is expected to drive the growth of the implantable neurostimulation devices market in the coming years. Neurological disorders are conditions that affect the structure or function of the nervous system, resulting in symptoms such as paralysis, seizures, and cognitive impairments. Greater exposure to risk factors such as high blood pressure, developmental abnormalities, trauma, or injury contributes to higher detection rates of these disorders. Implantable neurostimulation devices are used to modulate nerve activity and alleviate symptoms when conventional treatments are ineffective or insufficient. For example, according to the Alzheimer's Association, a US-based non-profit organization, an estimated 6.9 million Americans aged 65 and older were living with Alzheimer's disease in 2024, with 73% being 75 years or older. This number is projected to reach 12.7 million by 2050. Thus, the rising prevalence of neurological disorders is expected to fuel the demand for implantable neurostimulation devices.

Companies in the implantable neurostimulation devices market are focusing on developing advanced systems, such as rechargeable brain-sensing neurostimulators, to provide more personalized and adaptive therapy for patients with movement and neurological disorders. These devices are implanted to record real-time brain signals while delivering targeted stimulation, allowing clinicians to fine-tune therapy based on individual neural activity and long-term treatment requirements. For instance, in January 2024, Medtronic, a US-based medical device company, received U.S. Food and Drug Administration (FDA) approval for its Percept RC neurostimulator, a rechargeable deep brain stimulation (DBS) system featuring exclusive BrainSense technology. The device captures and tracks brain signals to optimize personalized therapy. It offers a service life of at least 15 years, flexible directional stimulation programming, and rapid recharging capabilities, providing patients with a durable and customizable option for managing movement disorders.

In September 2023, Amber Therapeutics, a UK-based provider of neuromodulation therapies, acquired Bioinduction for an undisclosed amount. This acquisition strengthens Amber's strategic capabilities by incorporating Bioinduction's implantable-device hardware, engineering expertise, and manufacturing know-how to support next-generation neuromodulation solutions. It also accelerates the development and commercialization of Amber-UI by integrating proven implantable neurostimulation technology into Amber's platform. Bioinduction is a UK-based manufacturer of implantable neurostimulation devices.

Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Curonix LLC, Inspire Medical Systems Inc., SetPoint Medical Corporation, ElectroCore Inc.

North America was the largest region in the implantable neurostimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable neurostimulation devices market consists of sales of responsive neurostimulation systems, peripheral nerve stimulation systems, cerebral spinal fluid shunt systems and electroceutical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Neurostimulation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses implantable neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Spinal Cord Stimulation (SCS); Gastric Electric Stimulation (GES); Deep Brain Stimulation (DBS); Sacral Nerve Stimulation (SNS); Vagus Nerve Stimulation (VNS); Other Types
  • 2) By Application: Pain Management; Parkinson's Disease; Urinary And Fecal Incontinence; Epilepsy; Gastroparesis; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices; Non-Rechargeable SCS Devices
  • 2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators; Adjustable Gastric Stimulators
  • 3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders; DBS Devices for Psychiatric Disorders
  • 4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence; SNS Devices for Fecal Incontinence
  • 5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy; VNS Devices for Depression
  • 6) By Other Types: Peripheral Nerve Stimulation (PNS); Cortical Stimulation Devices; Novel Neurostimulation Technologies
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; St. Jude Medical LLC; LivaNova PLC; Nevro Corp.; Axonics Inc.; NeuroPace Inc.; Bioness Inc.; Saluda Medical Pty Ltd.; SceneRay Co. Ltd.; NeuroMetrix Inc.; Synapse Biomedical Inc.; NeuroSigma Inc.; Nuvectra Corporation; MicroTransponder Inc.; Curonix LLC; Inspire Medical Systems Inc.; SetPoint Medical Corporation; ElectroCore Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Implantable Neurostimulation Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Implantable Neurostimulation Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Implantable Neurostimulation Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Implantable Neurostimulation Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Deployment Of Advanced Neurostimulation Therapies
    • 4.2.2 Rising Adoption Of Rechargeable Stimulation Devices
    • 4.2.3 Growing Use Of Personalized Neuromodulation Treatments
    • 4.2.4 Expansion Of Multi-Indication Neurostimulation Systems
    • 4.2.5 Enhanced Focus On Long-Term Therapy Effectiveness

5. Implantable Neurostimulation Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Neurology Clinics
  • 5.3 Pain Management Centers
  • 5.4 Ambulatory Surgical Centers
  • 5.5 Rehabilitation Centers

6. Implantable Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Implantable Neurostimulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Implantable Neurostimulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Implantable Neurostimulation Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Implantable Neurostimulation Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Implantable Neurostimulation Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Implantable Neurostimulation Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Implantable Neurostimulation Devices Market Segmentation

  • 9.1. Global Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types
  • 9.2. Global Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pain Management, Parkinson's Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
  • 9.3. Global Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Ambulatory Surgical Centers
  • 9.4. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulation (SCS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Rechargeable SCS Devices, Non-Rechargeable SCS Devices
  • 9.5. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Gastric Electric Stimulation (GES), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Gastric Stimulators, Adjustable Gastric Stimulators
  • 9.6. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Deep Brain Stimulation (DBS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders
  • 9.7. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Sacral Nerve Stimulation (SNS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence
  • 9.8. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Vagus Nerve Stimulation (VNS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • VNS Devices for Epilepsy, VNS Devices for Depression
  • 9.9. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies

10. Implantable Neurostimulation Devices Market Regional And Country Analysis

  • 10.1. Global Implantable Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Implantable Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Implantable Neurostimulation Devices Market

  • 11.1. Asia-Pacific Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Implantable Neurostimulation Devices Market

  • 12.1. China Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Implantable Neurostimulation Devices Market

  • 13.1. India Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Implantable Neurostimulation Devices Market

  • 14.1. Japan Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Implantable Neurostimulation Devices Market

  • 15.1. Australia Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Implantable Neurostimulation Devices Market

  • 16.1. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Implantable Neurostimulation Devices Market

  • 17.1. South Korea Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Implantable Neurostimulation Devices Market

  • 18.1. Taiwan Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Implantable Neurostimulation Devices Market

  • 19.1. South East Asia Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Implantable Neurostimulation Devices Market

  • 20.1. Western Europe Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Implantable Neurostimulation Devices Market

  • 21.1. UK Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Implantable Neurostimulation Devices Market

  • 22.1. Germany Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Implantable Neurostimulation Devices Market

  • 23.1. France Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Implantable Neurostimulation Devices Market

  • 24.1. Italy Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Implantable Neurostimulation Devices Market

  • 25.1. Spain Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Implantable Neurostimulation Devices Market

  • 26.1. Eastern Europe Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Implantable Neurostimulation Devices Market

  • 27.1. Russia Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Implantable Neurostimulation Devices Market

  • 28.1. North America Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Implantable Neurostimulation Devices Market

  • 29.1. USA Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Implantable Neurostimulation Devices Market

  • 30.1. Canada Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Implantable Neurostimulation Devices Market

  • 31.1. South America Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Implantable Neurostimulation Devices Market

  • 32.1. Brazil Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Implantable Neurostimulation Devices Market

  • 33.1. Middle East Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Implantable Neurostimulation Devices Market

  • 34.1. Africa Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Implantable Neurostimulation Devices Market Regulatory and Investment Landscape

36. Implantable Neurostimulation Devices Market Competitive Landscape And Company Profiles

  • 36.1. Implantable Neurostimulation Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Implantable Neurostimulation Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Implantable Neurostimulation Devices Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

37. Implantable Neurostimulation Devices Market Other Major And Innovative Companies

  • Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Curonix LLC, Inspire Medical Systems Inc., SetPoint Medical Corporation, ElectroCore Inc.

38. Global Implantable Neurostimulation Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Implantable Neurostimulation Devices Market

40. Implantable Neurostimulation Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Implantable Neurostimulation Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Implantable Neurostimulation Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Implantable Neurostimulation Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer